Cargando…

Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation

Recently, scary viral pneumonia is known as (COVID-19) has swept the whole world. The new virus strain designated as SARS-CoV-2 belonging to the coronavirus family. Although the current medical research directed towards the development of a novel therapeutic agent, no anti-viral drug approved until...

Descripción completa

Detalles Bibliográficos
Autor principal:	El-hoshoudy, A.N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399655/ https://www.ncbi.nlm.nih.gov/pubmed/32839634 http://dx.doi.org/10.1016/j.molliq.2020.113968

Ejemplares similares

Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation
por: Messaoudi, Omar, et al.
Publicado: (2021)

Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study
por: Peele, K. Abraham, et al.
Publicado: (2020)

In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
por: Khater, Ibrahim, et al.
Publicado: (2021)

In Silico Identification and Analysis of Potentially Bioactive Antiviral Phytochemicals against SARS-CoV-2: A Molecular Docking and Dynamics Simulation Approach
por: Halder, Sajal Kumar, et al.
Publicado: (2023)

Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
por: Calligari, Paolo, et al.
Publicado: (2020)

Probing marine brown macroalgal phlorotannins as antiviral candidate against SARS-CoV-2: molecular docking and dynamics simulation approach
por: Gunaseelan, Sathaiah, et al.
Publicado: (2022)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
por: Mahmud, Shafi, et al.
Publicado: (2021)

Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
por: Omer, Samia E., et al.
Publicado: (2022)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies
por: Al-Rabia, Mohammed W., et al.
Publicado: (2021)

Biological perspective of thiazolide derivatives against Mpro and MTase of SARS-CoV-2: Molecular docking, DFT and MD simulation investigations
por: Rasool, Nouman, et al.
Publicado: (2021)

Experimental and Theoretical Investigation of Glycol-Based Hydrogels through Waterflooding Processes in Oil Reservoirs Using Molecular Dynamics and Dissipative Particle Dynamics Simulation
por: El-hoshoudy, Abdelaziz N.
Publicado: (2021)

Molecular docking and dynamics simulation of main protease of SARS-CoV-2 with naproxen derivative
por: K Hussein, Rageh, et al.
Publicado: (2023)

Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations
por: Lazniewski, Michal, et al.
Publicado: (2022)

Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
por: Petit, Léna, et al.
Publicado: (2021)

Evaluation of Clove Phytochemicals as Potential Antiviral Drug Candidates Targeting SARS-CoV-2 Main Protease: Computational Docking, Molecular Dynamics Simulation, and Pharmacokinetic Profiling
por: Chandra Manivannan, Arun, et al.
Publicado: (2022)

Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2
por: Ouassaf, Mebarka, et al.
Publicado: (2021)

Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach
por: Pulakuntla, Swetha, et al.
Publicado: (2021)

DockCoV2: a drug database against SARS-CoV-2
por: Chen, Ting-Fu, et al.
Publicado: (2020)

Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis
por: Khater, Ibrahim, et al.
Publicado: (2022)

Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection
por: Liu, Xiao-huan, et al.
Publicado: (2021)

Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2
por: Anwaar, Muhammad U., et al.
Publicado: (2022)

Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (M(pro)) inhibitor using docking and molecular dynamics simulations
por: Patel, Chirag N., et al.
Publicado: (2021)

Correction to: Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
por: Petit, Léna, et al.
Publicado: (2021)

Molecular docking and simulation investigation: effect of beta-sesquiphellandrene with ionic integration on SARS-CoV2 and SFTS viruses
por: Joshi, Amit, et al.
Publicado: (2020)

In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches
por: Zhang, Chunye, et al.
Publicado: (2023)

Molecular docking, molecular dynamics simulation, and ADMET analysis of levamisole derivatives against the SARS-CoV-2 main protease (M(Pro))
por: EL Khatabi, Khalil, et al.
Publicado: (2022)

Molecular Docking and Dynamics Simulation of Several Flavonoids Predict Cyanidin as an Effective Drug Candidate against SARS-CoV-2 Spike Protein
por: Shrestha, Asmita, et al.
Publicado: (2022)

Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2
por: Rashid, Haroon ur, et al.
Publicado: (2022)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing
por: Mohamed, Eslam A. R., et al.
Publicado: (2023)

Phytochemicals from Selective Plants Have Promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations
por: Kousar, Kafila, et al.
Publicado: (2020)

Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2
por: Kodchakorn, Kanchanok, et al.
Publicado: (2020)

In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis
por: Gajjar, Normi D., et al.
Publicado: (2021)

A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme()
por: Ercan, Selami, et al.
Publicado: (2021)

DFT, molecular docking and molecular dynamics simulation studies on some newly introduced natural products for their potential use against SARS-CoV-2
por: Erdogan, Taner
Publicado: (2021)

Potential Antiviral Options against SARS-CoV-2 Infection
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Potential antiviral peptides against the nucleoprotein of SARS-CoV-2
por: Mahdi, Iktedar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7vu83pih8ikcsja9jvb0u7rqlt